Viruses can enter the body by diverse routes, infect almost every type of host cell and mutate to avoid immune recognition. Destroying rapidly dividing viruses efficiently requires the coordination of multiple immune effector mechanisms. At the earliest stages of infection, innate immune mechanisms are initiated in response to the binding of pathogens to pattern-recognition receptors (PRRs), and this stimulates the antiviral activities of innate immune cells to provide a crucial initial block on viral replication. Innate immune responses then mobilize cells of the adaptive immune system, which develop into effector cells that promote viral clearance.
Activation through PRRs causes professional antigenpresenting cells (APCs) to upregulate co-stimulatory molecules and promotes the migration of these cells to secondary lymphoid organs. Here, they present virusderived peptides on MHC class II molecules to naive CD4 + T cells and deliver co-stimulatory signals, thereby driving T cell activation. The activated CD4 + T cells undergo extensive cell division and differentiation, giving rise to distinct subsets of effector T cells
. The best characterized of these are T helper 1 (T H 1) and T H 2 cells, which are characterized by their production of interferon-γ (IFNγ) and interleukin-4 (IL-4), respectively 1 . Specialized B cell helpers, known as follicular helper T (T FH ) cells, and the pro-inflammatory T H 17 cell subset also develop, along with regulatory T (T Reg ) cells, which are essential for avoiding over-exuberant immune responses and associated immunopathology 2 . A key role of CD4 + T cells is to ensure optimal responses by other lymphocytes. CD4 + T cells are necessary as helpers to promote B cell antibody production and are often required for the generation of cytotoxic and memory CD8 + T cell populations. Recent studies have defined additional roles for CD4 + T cells in enhancing innate immune responses and in mediating non-helper antiviral effector functions. We discuss what is known about the T cell subsets that develop following acute viral infection and how different subsets contribute to viral control and clearance.
Following a rapid and effective antiviral response, infection is resolved and the majority of effector CD4 + T cells die, leaving a much smaller population of memory CD4 + T cells that persists long-term 3, 4 . Memory CD4 + T cells have unique functional attributes and respond more rapidly and effectively during viral re-infection. A better understanding of the functions of memory CD4 + T cells will allow us to evaluate their potential contribution to immunity when they are induced by either infection or vaccination. We describe the antiviral roles of CD4 + T cells during the first encounter with a virus and also following re-infection.
Generation of antiviral CD4
+ T cells To develop into effector populations that combat viral infections, naive CD4 + T cells need to recognize peptide antigens presented by MHC class II molecules on activated APCs. PRR-mediated signalling activates APCs to upregulate their expression of MHC class II molecules, co-stimulatory molecules (such as CD80 and CD86) and pro-inflammatory cytokines (such as type I IFNs, tumour necrosis factor (TNF), IL-1, IL-6 and IL-12) 5 . When the activated APCs migrate to draining lymph nodes, they prime naive virus-specific CD4 + T cells, which then differentiate into antiviral effectors (FIG. 1) . The priming environment can vary Pattern-recognition receptors (PRRs) . Host receptors that can detect pathogen-associated molecular patterns and initiate signalling cascades, leading to an innate immune response. Examples include Toll-like receptors (TLRs) and NOD-like receptors (NLRs). PRRs can be membrane-bound receptors (as in the case of TLRs) or soluble cytoplasmic receptors (as in the case of NLRs, retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5)).
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Abstract | Viral pathogens often induce strong effector CD4 + T cell responses that are best known for their ability to help B cell and CD8 + T cell responses. However, recent studies have uncovered additional roles for CD4 + T cells, some of which are independent of other lymphocytes, and have described previously unappreciated functions for memory CD4 + T cells in immunity to viruses. Here, we review the full range of antiviral functions of CD4 + T cells, discussing the activities of these cells in helping other lymphocytes and in inducing innate immune responses, as well as their direct antiviral roles. We suggest that all of these functions of CD4 + T cells are integrated to provide highly effective immune protection against viral pathogens.
T-bet
A member of the T-box family of transcription factors. T-bet is a master switch in the development of T helper 1 (T H 1) cell responses through its ability to regulate the expression of the interleukin-12 receptor, inhibit signals that promote T H 2 cell development and promote the production of interferon-γ.
dramatically during different viral infections and is influenced by many variables, including the route of infection, the viral dose and the organ or cell types targeted. As has been extensively reviewed elsewhere, the extent of T cell proliferation and the determination of T cell subset specialization are affected by the specific subset of APCs that is activated 6, 7 , the antigen load and the duration of antigen presentation 8 , and the patterns and amounts of cytokines produced by different APCs 9 .
Effector T H cell subsets in viral infection
In contrast to T H cell populations that are generated in vitro, effector T cells that are found in vivo are often characterized by plasticity and heterogeneity in terms of their cytokine-producing potential. Nevertheless, the CD4 + T cells that are generated in response to viral infection mainly have a T H 1-type phenotype and produce large amounts of IFNγ and express T-bet. This phenotype classically depends on the exposure of T cells to high levels of IL-12, type I IFNs and IFNγ in figure) . The differentiation of polarized effector T cells is controlled by unique sets of transcription factors, the expression of which is determined by multiple signals but particularly by soluble factors that act on responding CD4 + T cells during their activation. The elucidation of the crucial cytokines that govern the differentiation of distinct T H cell subsets has allowed researchers to examine the protective capacities of differently polarized CD4 + T cell subsets in several models of infectious disease. Although the production of the signature cytokines interferon-γ (IFNγ), interleukin-4 (IL-4) and IL-17 is routinely used to assign subsets (T H 1, T H 2 and T H 17, respectively) to responding CD4 + T cells, it is increasingly clear that considerable plasticity exists within T H cell subsets in vivo, especially during responses to pathogens. Moreover, certain cytokines (for example, IL-10) can be produced by subpopulations of cells within multiple effector subsets. Finally, the successful clearance of viral pathogens in particular often depends on complex CD4 + T cell responses that encompass multiple T H cell subsets. Together, these T cell subsets are capable of mediating direct antiviral functions, of providing help for B cells, of regulating immunopathology and of mediating cytotoxic killing of virus-infected cells. CD4 + T cells with cytotoxic activity have been described in several models of viral disease as well as in the clinic. Following re-stimulation, memory CD4
+ T cells retain their previous effector functions and rapidly produce effector cytokines. 28 or influenza virus 16 , although at levels lower than those of T H 1 cells. The generation of polarized T H 17 cells during viral infection has been correlated with high levels of IL-6 and may also be influenced by transforming growth factor-β (TGFβ) 28 . T H 17 cells are implicated in driving harmful inflammation during autoimmunity, and IL-17 may contribute to immunopathology during responses against viruses, as demonstrated in studies using influenza virus or vaccinia virus 27, 29 . However, in some cases, T H 17 cells contribute to host protection against viruses 16 . One protective mechanism mediated by T H 17 cells might be the promotion of enhanced neutrophil responses at sites of infection. IL-17 upregulates CXC-chemokines that promote neutrophil recruitment 30 , and neutrophils can contribute to protection against certain viruses, including influenza virus 31 . We expect that other roles for T H 
Class switching
The process by which proliferating B cells rearrange their DNA to switch from expressing the heavy-chain constant region of IgM (or another class of immunoglobulin) to expressing that of a different immunoglobulin class, thereby producing antibodies with different effector functions. The decision of which isotype to generate is strongly influenced by the specific cytokine milieu and by other cells, such as T helper cells.
Germinal centre
A highly specialized and dynamic microenvironment that gives rise to secondary B cell follicles during an immune response. Germinal centres are the main site of B cell maturation, which leads to the generation of memory B cells and plasma cells that produce high-affinity antibodies.
Polyinosinic-polycytidylic acid
(PolyI:C). A substance that is used as a mimic of viral double-stranded RNA. 
Roles of CD4 + T cells during primary infection
CD4
+ T cell-mediated help for B cells. Current licensed vaccines directed against viral pathogens are evaluated almost exclusively on their ability to generate strong neutralizing antibody responses. Antibody-mediated protection can be extraordinarily long-lived 33 , and neutralizing antibodies present at the time of pathogen encounter can prevent rather than combat infection, thereby achieving 'sterilizing' immunity. Thus, it is crucial to understand the mechanisms by which Following viral infection, the expression of SLAMassociated protein (SAP) by T FH cells is necessary to direct the formation of germinal centres 36, 37 , where T FH cells promote the generation of B cell memory and long-lived antibody-producing plasma cells 36, 38 . Thus, T FH cells are likely to be important for generating longlived antibody responses and protective immunity to most, if not all, viruses. Indeed, CD4 + T cells have been shown to be required for the generation of optimal antibody responses following infection with coronavirus 39 , vaccinia virus 40 , yellow fever virus 41 or vesicular stomatitis virus (VSV) 42 . It is not yet clear how distinct cytokine-polarized CD4 + T cell subsets influence the B cell response during primary viral infection. One possibility is that distinct T H cell subsets, such as T H 1, T H 2 and T H 17 cells, can each develop into T FH cells and provide efficient help for B cells. This hypothesis is supported by a recent study demonstrating that such polarized subsets can be reprogrammed to express T FH cell characteristics in vitro 43 . As different T H cell subsets have been associated with distinct antibody classswitching responses, the broad range of protective antibody isotypes that is often found in individuals with immunity to a virus favours such a model.
Several co-stimulatory ligands expressed by CD4 + T cells contribute to the promotion of B cell activation and antibody production. One notable ligand is CD40 ligand (CD40L). Interactions between CD40 (which is expressed on B cells) and CD40L (which is expressed on activated CD4 + T cells) are crucial for generating optimal humoral responses against several viral pathogens, including LCMV, Pichinde virus, VSV, HSV and influenza virus [44] [45] [46] . The expression of inducible T cell costimulator (ICOS) by T FH cells has also been shown to be important for germinal centre formation 34 , and ICOS expression is required for optimal induction of humoral responses against LCMV, VSV and influenza virus 47 , Venezuelan equine encephalitis virus 88 , coronavirus 89 , VSV 90 and Friend virus 91, 92 . In many cases, the direct protective mechanism used by CD4 + T cells has not been defined. However, effector CD4 + T cells have, in general, been shown to protect against viral pathogens through two distinct mechanisms: first, through the production of cytokines, most notably IFNγ and TNF 98 . Thus, effector CD4 + T cells that migrate to infected tissues probably promote viral clearance through both cytotoxic and cytokine-dependent mechanisms.
Immunoregulation by effector CD4 + T cells Effector CD4 + T cells are capable of potent immunoregulation at sites of infection. A subset of T H 1 cells has been found to transiently produce both IFNγ and IL-10 at the peak of the effector CD4 + T cell response in many models of infectious disease 99 . Several signals have been found to stimulate the generation of IL-10-producing effector CD4 + T cells, including high levels of antigen, soluble factors such as IL-12 and IL-27, and co-stimulatory signals such as ICOS (reviewed in REF. 99 ). IL-10 is a pleiotropic cytokine that is most often associated with antiinflammatory or inhibitory functions (FIG. 3) . The impact of IL-10 production by effector CD4 + T cells is complicated and can be variable, especially in situations in which strong immune responses (which are capable of serious immunopathology) are required to eliminate a rapidly replicating pathogen. For instance, the absence of IL-10 during influenza virus infection can lead, on the one hand, to improved host survival, owing to enhanced T cell 16 and antibody 100 responses, but also, on the other hand, to exacerbated inflammation and immunopathology, which result in increased mortality 101 . Similarly, ablating Il10 has been found to enhance protection against WNV 102 and vaccinia virus 103 , but to cause increased pathology following infection with RSV 104 and death following infection with mouse hepatitis virus 105 or coronavirus 106 . Finally, as well as producing IL-10 themselves, effector CD4 + T cells can also promote IL-10 production by effector CD8 
Regulatory CD4 + T cells Increased frequencies of CD4
+ T Reg cells (of both the forkhead box P3 (FOXP3) + and FOXP3 -populations) have been observed in numerous human and animal studies of viral infection. Most studies that have assessed the impact of T Reg cells during viral infection have concentrated on models of chronic infection. In such settings, T Reg cells have been found, depending on the particular pathogen, to have both beneficial roles, such as limiting collateral tissue damage, and detrimental roles, including diminishing the overall magnitude of antiviral immune responses 108 . The antigen specificity of T Reg cells in the context of infectious disease has not been addressed often, but it is likely that T Reg cell populations contain at least some virus-specific cells and that these populations are generated in concert with antiviral effector T cell responses. Indeed, this has recently been shown in a coronavirus infection model 109 . The accumulation of virus-specific FOXP3 + T Reg cells during viral infection could be due to the expansion of pre-existing populations of thymus-derived 'natural' T Reg cells that are specific for viral antigens, or could also reflect the de novo generation of 'induced' T Reg cells from naive virus-specific CD4 + T cells. An important factor in the generation of induced T Reg cells appears to be TGFβ 110, 111 , although how induced T Reg cells affect viral infection is not yet well understood. For example, some viral pathogens may promote the development of T Reg cell populations to limit the host antiviral response. Evidence for this hypothesis has been found in several models, mainly of chronic viral infection 112, 113 . In acute viral infection, which has not been studied as fully as chronic infection, T Reg cells have been shown to limit pathology during infection with WNV 114 [157] [158] [159] . Importantly, clinical evidence also correlates the presence of higher numbers of IL-21-producing CD4 + T cells with improved CD8 + T cell function and improved control of HIV infection 160, 161 . These observations suggest new avenues that could improve vaccination strategies and adoptive transfer therapies 162 through the generation of CD4 + T cell populations specifically geared towards the provision of maximal help in the context of chronic infection.
Box 3 | Tissue-resident memory T cells
Following the resolution of primary immune responses, most effector T cells die by apoptosis, leaving behind a small population of long-lived memory cells. Recent studies have demonstrated that, in addition to recirculating through lymphoid and non-lymphoid tissues, some memory cells reside at sites of infection. Although most of these studies have concentrated on CD8 + T cell memory, CD4 + T cells also appear to survive for long periods in peripheral tissues 163, 164 . Often, the expression of distinct surface proteins distinguishes tissue-specific memory cells from conventional lymphoid memory populations. These molecules are likely to have a crucial role in the retention of memory T cells at different sites through specific interactions with ligands that are expressed in particular tissues. For example, the expression of α1β1 integrin (also known as VLA1) by airway-resident memory CD4 + T cells in the lungs can facilitate binding to collagen 164 , and high levels of CD103 expression by brain-or skin-resident memory CD8 + T cells facilitates their interaction with cells that express E-cadherin 165, 166 . Tissue-resident memory T cells act as a first line of defence. Combined with the ability of memory T cells, but not naive T cells, to be activated through the recognition of antigens in peripheral tissues 132, 167 , the location of memory CD4 + T cell populations at potential sites of re-infection represents a powerful advantage of the memory state over the naive state, in which a lag of several days precedes the influx of antigen-specific cells into infected sites. Tissue-resident memory cells may facilitate more-rapid recruitment and activation of innate cell populations that are capable of controlling initial viral titres. Moreover, these memory cells may simultaneously accelerate the development of pathogen-specific effector populations of B and T cells by promoting the earlier activation of antigen-presenting cells. Elucidating the important cues that drive the development of long-lived tissue-resident memory cells is likely to become an important area of research, especially as this understanding may lead to the design of improved vaccination strategies.
high levels of antigen following the priming phase 121 and seems not to be regulated by the intrinsic changes in APCs that are caused by chronic viral pathogens 120 . Chronic infection may not lead to irreversible exhaustion of responding CD4 + T cells. For example, functionally impaired CD4 + T cells have been observed in patients with HIV, and treatment with antibodies that stimulate CD28 (REF. 122 ), block T cell immunoglobulin domain and mucin domain protein 3 (TIM3) 123 or block PD1 signalling 124 dramatically increased the proliferative potential of these T cells in vitro. Also, a recent study by Fahey et al. found that during chronic LCMV infection responding CD4 + T cells progressively adopt a functional T FH cell pheno type 125 . That CD4 + T cells may retain specific functions during chronic infection helps to explain earlier observations that persistent LCMV infection is eventually cleared through mechanisms that are dependent on CD4 + T cells
. For instance, interactions between exhausted CD8 + T cells and CD4 + T cells may restore CD8 + T cell function during chronic infection with LCMV 126 . These findings and others (reviewed in REFS 127, 128) have important implications for the design of vaccines against viruses that cause chronic infection in humans (such as HIV, hepatitis B and hepatitis C).
Memory CD4
+ T cell responses against viruses Following the resolution of infection, or after successful vaccination, most virus-specific effector CD4 + T cells die. This leaves a small population of memory T cells, which ensures that the frequency of virus-specific T cells is greater than it was before priming. The population of CD4 + memory T cells diminishes with time and may require boosting. It is unclear which responding effector CD4 + T cells make the transition to a memory phenotype, but a recent study suggests that those with lower expression of LY6C and T-bet have a greater potential to do so 129 . A quantitative gain in antigen-specific cells represents one important advantage of the memory state, but memory T cells also differ from naive T cells by broad functional criteria. Compared with naive T cells, memory CD4 + T cells respond much faster, respond to lower antigen doses, require less co-stimulation and proliferate more vigorously following pathogen challenge 130 . In addition, subpopulations of memory CD4 + T cells have wider trafficking patterns and some are retained at or near sites of previous infection 131 , and this contributes to their ability to be rapidly activated following local re-infection. Tissue tropism and/or retention of tissue-resident memory CD4 + T cells may depend on specific interactions between adhesion molecules and their receptors
.
Memory CD4 + T cells enhance early innate immune responses following viral infection. Memory CD4
+ T cell-mediated recognition of antigens presented by APCs following re-infection has rapid consequences. Within 48 hours of intranasal infection with influenza virus, antigen-specific memory CD4 + T cells cause an enhanced inflammatory response in the lung, and this is characterized by the upregulation of a wide array of pro-inflammatory mediators 132 (FIG. 4) . In infected tissues, transferred T H 1-type and T H 17-type memory cells, as well as memory CD4 + T cells generated by previous infections, upregulate the expression of proinflammatory cytokines and chemokines, including 16, 86, 132 . A similar impact of memory CD4 + T cells on early viral control during secondary influenza infection was recently reported by Chapman et al. 134 , and this also correlated with a dramatic enhancement of innate immune responses against the virus. However, this effect has not yet been studied in other models of viral infection.
We suggest that the early activation of innate immune mechanisms by memory CD4 + T cells serves to lessen the 'stealth phase' of infection, during which titres of the virus are still too low to generate robust inflammatory responses 135 . This would prevent viruses from gaining a 'foothold' in the host by infecting and replicating in cells at a level that is below immune detection. Importantly, the induction of early innate immune responses by memory CD4 + T cells does not require PRR activation 132 and could therefore be important for enhancing protection against viral pathogens -such as vaccinia virus and influenza virus -that can actively antagonize key components of innate recognition pathways, such as dsRNA-dependent protein kinase (PKR) 136 . One intriguing finding is that memory CD4 + T cells specific for ovalbumin enhance antiviral immunity when ovalbumin is co-administered with an influenza virus that does not express ovalbumin 132 . Thus, we hypothesize that the induction of innate immune responses by memory CD4 + T cells could have an adjuvant effect, which could be exploited (and substituted for PRR stimulation 132 ) to promote immune responses to vaccines that do not contain live viruses. For example, a vaccine could activate the innate immune system through antigen-specific stimulation of memory CD4 + T cells that are known to be widespread in the human population (for example, most individuals have memory CD4 + T cells specific for tetanus toxin). This method could possibly enhance the immunogenicity of 'weak' vaccines.
Heterologous memory responses. Heterologous viral immunity occurs when memory T cells that were generated in response to a particular virus cross-react with epitopes expressed by other, unrelated viruses. It has recently become clear that this is quite a widespread phenomenon that is likely to be important in the human population, as humans are exposed to numerous antigens as a result of infection and vaccination 137 .
Although heterologous immune responses can be protective, they may in some cases be deleterious and can result in dramatic immunopathology 138 . It will be important to determine to what extent the ability of memory CD4 + T cells to induce innate immunity contributes to both beneficial and deleterious heterologous responses.
Helper functions of memory CD4
+ T cells. Several studies indicate that memory CD4 + T cells are superior to naive T cells in providing help for B cells, and they have been shown to promote earlier B cell proliferation, higher antibody levels and earlier class-switching responses compared with naive CD4 + T cells [139] [140] [141] . In many cases, when pre-existing circulating antibodies are able to recognize the virus, re-infection may never occur. Faster antibody production could be particularly important after re-infection with rapidly mutating viruses (such as influenza virus), as the generation of neutralizing antibodies specific for new variants that evade previously generated antibodies could be necessary for immunity.
That memory CD4 + T cells are superior helpers for B cells compared with naive T cells is suggested by multiple criteria, and many mechanisms may contribute. Memory CD4 + T cells contain preformed stores of CD40L, an important signal in CD4 + T cellmediated help for antibody production 142 . The location of memory CD4 + T cells may also be an advantage. For example, antigen-specific memory CD4
+ T cells with a T FH cell phenotype are retained in the draining lymph nodes of mice for over 6 months following immunization 143 . The increased levels and polarized profile of cytokines produced by memory CD4 + T cells, as compared with those of naive T cells, is likely to promote a more-robust B cell antibody response and to dictate the antibody isotype, which has a key role in the efficacy of antibodies specific for viruses such Ebola virus 144 , WNV 145 and influenza virus 146 . Recent observations suggest that IL-4 and IFNγ produced by T FH cells have a central role in driving not only immunoglobulin class switching in the germinal centre, but also B cell affinity maturation 147 . Whether memory CD4 + T cells are superior to naive CD4 + T cells at providing help for primary or secondary CD8 + T cell responses during viral infection has not been rigorously tested. However, the features of memory cells described here suggest that memory CD4 + T cells could promote an accelerated response by naive CD8 + T cells, both through more-rapid licensing of APCs and through faster and more-robust production of IL-2 and possibly other cytokines; these possibilities need to be explored. In support of this concept, a study using Listeria monocytogenes found that T H 1-type but not T H 2-type memory CD4 + T cells enhanced primary CD8 + T cell responses in terms of both magnitude and cytokine production, although the mechanism of memory CD4 + T cell-mediated help was not determined 148 . Whatever the pathways involved, the fact that memory CD4 + T cells enhance the generation of CD8 + T cell memory and that this process has a greater dependence on CD4 + T cell-mediated help when PRR stimulation is limited suggests that CD4 + T cell-mediated help will be of particular importance in achieving optimal CD8 + T cell memory responses with vaccines that do not contain live, replication-competent viruses.
Finally, we should point out that the impact of memory CD4 + T cells on the early innate immune response may also affect subsequent antigen-specific immune responses against viruses, owing to alterations in the expression of chemokines. For example, by upregulating local production of CC-chemokine receptor 5 (CCR5) ligands at the site of infection, memory CD4 + T cells can promote the recruitment of memory CD8 + T cells that contribute to early viral control in influenza virus infection 149 . In HSV-2 infection, IFNγ expression by CD4 + T cells is required to induce chemokines that recruit effector CD8 + T cells to the infected vaginal tissue 150 . Similar roles for CD4 + T cells in promoting CD8 + T cell recruitment may occur during infections with other viruses, although it is often difficult to separate the roles of CD4 + T cells in generating effector CD8 + T cells from their roles in modifying CD8
+ T cell trafficking 39, 85, 151 .
Secondary effector T cells
The presence of memory CD4 + T cells that are capable of producing multiple cytokines has been correlated with superior protective capacity in numerous studies 152 , but how such cells achieve enhanced protection has not been addressed. One possibility is that 'secondary' effector CD4 + T cells that arise from memory precursors may be much more efficient in directly combating pathogens than primary effector CD4 + T cells that arise from naive cells. Our recent experiments that directly compared such primary and secondary effectors during influenza virus infection support such a view (T.M.S., K.K.M., L. M. Bradley and S.L.S., unpublished observations). We found that following adoptive transfer of either antigen-specific memory CD4 + T cells or an equal number of antigen-specific naive CD4 + T cell pre cursors, the secondary effector populations that developed from the memory CD4 + T cells showed greater expansion and contained higher frequencies of T cells that secrete multiple cytokines. Furthermore, although high levels of IL-10 were produced by primary effector CD4 + T cells during influenza virus infection, secondary effector cells produced much less IL-10. Thus, memory CD4 + T cells seem to give rise to secondary effector T cells that are distinct from and superior to the primary effectors derived from naive CD4 + T cells. We suggest that this results in more-protective recall responses, and we predict that further functions of secondary effectors will be discovered as additional comparative analyses are carried out. The picture that emerges is one in which CD4 + T cells carry out an impressive variety of functions at different times and in different sites, and we suggest that the synergy of these distinct mechanisms can provide an extraordinarily high level of viral control. Depending on the particular pathogen and the level of infection, these mechanisms may often be redundant, but they are likely to each make key contributions following exposure to high doses of rapidly replicating viruses or to viruses that have evolved mechanisms to evade specific immune pathways. We point out that the study of the immune response to viral infections has revealed new mechanisms by which CD4 + T cells function to protect against pathogens, and we predict that additional mechanisms will be identified in the future. Thus, this area of study will lead to a better understanding of how vaccines can be designed to harness the power of CD4 + T cell memory.
